Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
ID: 356019Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $750K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research," aimed at advancing research through collaborative efforts. This initiative encourages research teams to form groups of three to six principal investigators to tackle significant challenges in the DOC fields, requiring a well-defined scientific goal and a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity. With a total funding of $3 million available annually to support 2-3 projects, each project can receive up to $750,000 in direct costs per year for a duration of up to five years. Interested applicants should note that the application deadline is November 19, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is issuing a funding opportunity aimed at advancing dental, oral, and craniofacial (DOC) research through collaborative science. Under the funding initiative RM1, eligible research teams are encouraged to present well-defined, transdisciplinary projects that aim to address significant challenges in the DOC fields, drawing expertise from diverse disciplines. Applicants must form teams comprising three to six principal investigators (PDs/PIs) and submit an integrated research plan that includes a Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity. Funding of $3 million annually will support 2-3 projects, with a maximum of $750,000 allowed in direct costs per year over a duration of up to five years. This initiative highlights the role of team science in achieving disruptive innovations and mandates that applications demonstrate robust management and communication strategies among team members. With application deadlines set for October 2024, the NIH emphasizes early submission and compliance with stringent guidelines to ensure successful grant acquisition. The overarching goal is to significantly improve DOC health outcomes through collaborative and innovative research approaches.
    Similar Opportunities
    Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)" aimed at advancing the development of organ-on-a-chip (OoC) technologies for dental, oral, and craniofacial research. This initiative seeks to support interdisciplinary research that validates these microfluidic systems for disease modeling and pre-clinical efficacy studies, with the goal of establishing OoC technologies as viable alternatives to animal models. A total of $2 million is allocated for 4-5 grants, with individual project budgets capped at $500,000 annually and a project duration of up to five years. Applications are due by November 19, 2024, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering an R21 exploratory/developmental grant aimed at funding innovative research in the development of organ-on-a-chip (OoC) models for dental, oral, and craniofacial (DOC) applications. The primary objective is to validate these microfluidic systems for disease modeling and pre-clinical efficacy studies, promoting a multidisciplinary approach that integrates fields such as bioengineering and computational biology. This initiative is crucial for enhancing drug testing and improving preclinical models, ultimately leading to better clinical trial designs and reducing reliance on animal testing. The total funding available for FY 2025 is $1 million, with individual awards capped at $275,000 over two years. Applications are due by November 19, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), is offering a funding opportunity for the continuation or revision of ongoing clinical trials via a Cooperative Agreement (UH3) mechanism. This initiative aims to support clinical trials that require additional time for completion or modifications to their scope, particularly focusing on innovative treatments for dental, oral, or craniofacial diseases. Eligible applicants include a diverse range of institutions, with no budget limits specified, and the total funding available will depend on NIH appropriations and the quality of applications submitted. Interested parties should note that the application deadline is January 8, 2025, and are encouraged to contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIDCR Drug, Biologic, Device, and Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement, designated as UG3/UH3. This initiative aims to support the planning and execution of clinical trials that enhance dental, oral, and craniofacial health, utilizing a two-phased approach: a one-year UG3 planning phase followed by a potential five-year UH3 implementation phase. Eligible applicants include higher education institutions, nonprofits, and local or state governments, with a focus on proposals that test FDA-regulated products and involve significant NIH engagement. Interested parties should note that the application deadline is January 6, 2028, and can find further details and contact information at grantsinfo@nih.gov or through the provided link to the full opportunity announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-057.html.
    Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the continuation or revision of clinical trials under the National Institute of Dental and Craniofacial Research (NIDCR) through a UH3 Exploratory/Developmental Cooperative Agreement. This initiative aims to support competing renewals or competitive revisions of ongoing clinical trials that focus on dental, oral, and craniofacial health, emphasizing the importance of structured data generation in advancing healthcare research. Eligible applicants include a wide range of institutions, such as public and private entities, nonprofits, and government organizations, with the application deadline set for January 6, 2028. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries regarding the application process.
    NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Funding Opportunity Announcement (FOA) for the NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3), aimed at supporting research applications focused on planning and executing clinical trials related to dental, oral, and craniofacial health. This funding opportunity is structured in two phases: an initial one-year planning phase (UG3) followed by a potential five-year implementation phase (UH3), contingent upon meeting specific scientific milestones and feasibility requirements. The initiative seeks to expedite the development of evidence-based approaches to improve health outcomes in dentistry, emphasizing rigorous adherence to ethical and regulatory standards throughout the trial process. Interested applicants, including various higher education institutions and nonprofit organizations, must submit their applications by January 8, 2025, and can find additional information at the NIH grants website or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development" (R03 Clinical Trial Not Allowed), aimed at supporting innovative research projects that utilize existing dental, oral, or craniofacial databases for secondary statistical analyses or the development of new statistical methodologies. This funding opportunity is particularly focused on studies that do not involve clinical trials and emphasizes the importance of addressing causal relationships in dental and oral health, with a goal of advancing clinical practices and knowledge. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government organizations, with funding available for direct costs up to $100,000 per year, totaling a maximum of $200,000 over two years. Interested parties must submit their applications electronically via Grants.gov by May 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), has announced a funding opportunity for Small Research Grants (R03) aimed at analyzing existing genomic data related to dental, oral, and craniofacial health. This initiative encourages projects that utilize publicly available genomic data and advanced methodologies, focusing on oral health disparities and biological pathways to identify intervention targets. The grant supports projects with budgets up to $200,000 over two years, with applications due by May 7, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute of Dental and Craniofacial Research (NIDCR) for investigator-initiated observational studies or biomarker validation studies that require prospective data collection. This cooperative agreement aims to support research that enhances oral health by generating robust clinical data and validating biomarkers with established preliminary data. The funding is available for projects up to five years, contingent upon NIH appropriations, and emphasizes the significance of the proposed research and the investigator's capability. Interested applicants can find more information and application guidelines at the provided link, with the application due date set for May 7, 2026, and inquiries directed to grantsinfo@nih.gov.
    NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NIDCR Small Grant Program for New Investigators (R03), aimed at supporting early-stage scientists in the fields of oral, dental, and craniofacial research. This grant program is designed for New Investigators who have not previously received substantial independent R01 funding, enabling them to conduct pilot or feasibility studies that will generate preliminary data necessary for future competitive R01 applications. By fostering research in this critical area of public health, the program seeks to empower emerging researchers to address significant questions aligned with the NIDCR's mission. Eligible applicants can request funding of up to $100,000, with a submission deadline of January 25, 2025. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the program's webpage at http://grants.nih.gov/grants/guide/pa-files/PAR-21-084.html.